{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:04:24Z","timestamp":1774559064345,"version":"3.50.1"},"reference-count":41,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.1210\/jc.2009-2088","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T00:35:57Z","timestamp":1268786157000},"page":"2113-2122","source":"Crossref","is-referenced-by-count":48,"title":["Treatment with Recombinant Human Insulin-Like Growth Factor (rhIGF)-I\/rhIGF Binding Protein-3 Complex Improves Metabolic Control in Subjects with Severe Insulin Resistance"],"prefix":"10.1210","volume":"95","author":[{"given":"Fiona M.","family":"Regan","sequence":"first","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Margot","family":"Umpleby","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology (A.M.U.), Postgraduate Medical School, University of Surrey, Guildford GU2 7WG, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo L.","family":"Acerini","sequence":"additional","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"},{"name":"Institute of Metabolic Science (C.L.A., S.O., R.H., R.K.S., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"O'Rahilly","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science (C.L.A., S.O., R.H., R.K.S., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"},{"name":"Institute of Metabolic Science (C.L.A., S.O., R.H., R.K.S., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Semple","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science (C.L.A., S.O., R.H., R.K.S., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Dunger","sequence":"additional","affiliation":[{"name":"Department of Paediatrics (F.M.R., R.M.W., A.M., C.L.A., R.H., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"},{"name":"Institute of Metabolic Science (C.L.A., S.O., R.H., R.K.S., D.B.D.), The University of Cambridge, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114063151700_R1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(54)80113-2","article-title":"Leprechaunism: a euphemism for a rare familial disorder","volume":"45","author":"Donohue","year":"1954","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041114063151700_R2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114063151700_R3","first-page":"193","article-title":"Insulin resistance: the clinical spectrum","volume":"6","author":"Mantzoros","year":"1995","journal-title":"Adv Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bst0290513","article-title":"Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors","volume":"29","author":"Siddle","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"key\n\t\t\t\t2019041114063151700_R5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199011153232016","article-title":"Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall\u2019s syndrome","volume":"323","author":"Quin","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114063151700_R6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00400998","article-title":"Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance","volume":"34","author":"Schoenle","year":"1991","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114063151700_R7","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI116109","article-title":"Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus","volume":"90","author":"Zenobi","year":"1992","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114063151700_R8","first-page":"1325","article-title":"In vivo metabolic effects of insulin-like growth factor-I not mediated through the insulin receptor","volume":"80","author":"Dozio","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diab.42.5.696","article-title":"Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes","volume":"42","author":"Kuzuya","year":"1993","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114063151700_R10","first-page":"799","article-title":"Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I","volume":"79","author":"Longo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jcem.83.2.4602","article-title":"Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism","volume":"83","author":"Nakae","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/joe.0.1410177","article-title":"Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance","volume":"141","author":"Quin","year":"1994","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t2019041114063151700_R13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s001250050695","article-title":"A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism","volume":"40","author":"Takahashi","year":"1997","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114063151700_R14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1360475","article-title":"Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus","volume":"136","author":"Vestergaard","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114063151700_R15","first-page":"205","article-title":"Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance","volume":"79","author":"Morrow","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1203\/00006450-199412000-00012","article-title":"Effect of intravenous insulin-like growth factor I in two patients with leprechaunism","volume":"36","author":"Backeljauw","year":"1994","journal-title":"Pediatr Res"},{"key":"key\n\t\t\t\t2019041114063151700_R17","first-page":"1518","article-title":"The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity","volume":"85","author":"Clemmons","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ghir.2005.05.002","article-title":"Rh\/IGF-I\/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose","volume":"15","author":"Clemmons","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041114063151700_R19","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1210\/jc.2006-2699","article-title":"Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes","volume":"92","author":"Clemmons","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R20","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1210\/jc.2004-0243","article-title":"Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I\/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes","volume":"89","author":"Saukkonen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.2006.02600.x","article-title":"Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates","volume":"65","author":"Williams","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114063151700_R22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1151174","article-title":"Mutations in the pericentrin (PCNT) gene cause primordial dwarfism","volume":"319","author":"Rauch","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114063151700_R23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-5448.2008.00470.x","article-title":"Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: confirmation of a syndrome","volume":"10","author":"Hussain","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"key\n\t\t\t\t2019041114063151700_R24","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/hmg\/ddp161","article-title":"SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway","volume":"18","author":"Cliffe","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2019041114063151700_R25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.73.1.25","article-title":"Body mass index reference curves for the UK, 1990","volume":"73","author":"Cole","year":"1995","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019041114063151700_R26","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1152\/ajpendo.00499.2001","article-title":"The hot IVGTT two-compartment minimal model: an improved version","volume":"284","author":"Toffolo","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS\u2014a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Statist Comput"},{"key":"key\n\t\t\t\t2019041114063151700_R28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/clinchem\/39.4.578","article-title":"Enzyme immunoassay for intact human insulin in serum or plasma","volume":"39","author":"Andersen","year":"1993","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041114063151700_R29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041114063151700_R30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/(SICI)1096-9888(199609)31:9<961::AID-JMS359>3.0.CO;2-H","article-title":"Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo","volume":"31","author":"Shojaee-Moradie","year":"1996","journal-title":"J Mass Spectrom"},{"key":"key\n\t\t\t\t2019041114063151700_R31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0003-2697(71)90284-3","article-title":"Analysis of trimethylsilyl O-methyloximes of carbohydrates by combined gas-liquid chromatography-mass spectrometry","volume":"43","author":"Laine","year":"1971","journal-title":"Analyt Biochem"},{"key":"key\n\t\t\t\t2019041114063151700_R32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425255.4.3.311","article-title":"Mecasermin rinfabate: rhIGF-I\/rhIGFBP-3 complex: iPLEX","volume":"4","author":"Williams","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key\n\t\t\t\t2019041114063151700_R33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2337\/diab.43.2.247","article-title":"Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance","volume":"43","author":"Moller","year":"1994","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114063151700_R34","first-page":"Elsevier","article-title":"Syndromes of severe insulin resistance and\/or lipodystrophy","volume":"London","author":"Semple","year":"2009","journal-title":"In: Weiss RE, Refetoff S, eds. Genetic diagnosis of endocrine disorders."},{"key":"key\n\t\t\t\t2019041114063151700_R35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2003-031274","article-title":"Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes","volume":"89","author":"Simpson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng872","article-title":"\u03b2-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter \u03b2-cell mass","volume":"31","author":"Kulkarni","year":"2002","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114063151700_R38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng1787","article-title":"Total insulin and IGF-I resistance in pancreatic \u03b2-cells causes overt diabetes","volume":"38","author":"Ueki","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114063151700_R39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/adc.71.2.144","article-title":"Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I","volume":"71","author":"Ishihama","year":"1994","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019041114063151700_R40","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1210\/jc.2005-1389","article-title":"Recombinant, nonglycosylated human insulin-like growth factor-binding protein-3 (IGFBP-3) is degraded preferentially after administration to type II diabetics, resulting in increased endogenous glycosylated IGFBP-3","volume":"90","author":"Clemmons","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114063151700_R41","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/5\/2113\/9067128\/jcem2113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T02:24:39Z","timestamp":1591151079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/5\/2113\/2596682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-2088","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}